Celltrion
068270.KS
#754
Rank
S$35.66 B
Marketcap
$172.20
Share price
0.72%
Change (1 day)
4.78%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total debt

Total debt on the balance sheet as of March 2024 : S$2.13 Billion

According to Celltrion 's latest financial reports the company's total debt is S$2.13 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Celltrion - Total debt on balance sheet (from 2007 to 2024)

Total debt by year

Year Total debt Change
2022-12-31S$0.84 B-0.39%
2021-12-31S$0.84 B-10.32%
2020-12-31S$0.94 B63.28%
2019-12-31S$0.57 B-8.64%
2018-12-31S$0.63 B-21.38%
2017-12-31S$0.80 B-1.36%
2016-12-31S$0.81 B-14.89%
2015-12-31S$0.95 B-6.1%
2014-12-31S$1.01 B13.24%
2013-12-31S$0.90 B27.63%
2012-12-31S$0.70 B51.55%
2011-12-31S$0.46 B48.16%
2010-12-31S$0.31 B3.64%
2009-12-31S$0.30 B13.57%
2008-12-31S$0.26 B530.47%
2007-12-31S$42.35 M